CBD-carbamate-C16
cannabidiol (CBD), a non-psychoactive component of cannabis
General
Type : Carbamate,Cannabinoid-Receptor-ligand
Chemical_Nomenclature : 6-Hydroxy-50-methyl-4-pentyl-2'-(prop-1-en-2-yl)-10,20,30,40-tetrahydro-[1,10-biphenyl]-2-yl (4-chlorobenzyl) (methyl)carbamate
Canonical SMILES : C1(=C(C=C(C=C1OC(=O)N(CC2=CC=C(C=C2)Cl)C)CCCCC)O[H])C3C(C(C)=C)CCC(=C3)C
InChI : InChI=1S\/C30H38ClNO3\/c1-6-7-8-9-23-17-27(33)29(26-16-21(4)10-15-25(26)20(2)3)28(18-23)35-30(34)32(5)19-22-11-13-24(31)14-12-22\/h11-14,16-18,25-26,33H,2,6-10,15,19H2,1,3-5H3
InChIKey : OHHCIRJUIDNYFH-UHFFFAOYSA-N
Other name(s) :
MW : 496.08
Formula : C30H38ClNO3
CAS_number :
PubChem :
UniChem : OHHCIRJUIDNYFH-UHFFFAOYSA-N
IUPHAR :
Wikipedia :
Target
References (1)
| Title : Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease - Jiang_2021_Eur.J.Med.Chem_223_113735 |
| Author(s) : Jiang X , Zhang Z , Zuo J , Wu C , Zha L , Xu Y , Wang S , Shi J , Liu XH , Zhang J , Tang W |
| Ref : Eur Journal of Medicinal Chemistry , 223 :113735 , 2021 |
| Abstract : Jiang_2021_Eur.J.Med.Chem_223_113735 |
| ESTHER : Jiang_2021_Eur.J.Med.Chem_223_113735 |
| PubMedSearch : Jiang_2021_Eur.J.Med.Chem_223_113735 |
| PubMedID: 34371367 |